Bluejay Diagnostics, Inc. announced completion of its previously planned clinical studies for the Symphony IL-6 Test. Results of these studies will be published at the 2022 AACC Annual Scientific Meeting being held July 26th to 28th in Chicago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.01 USD | -10.68% |
|
-26.23% | -69.16% |
05-31 | Bluejay Diagnostics, Inc. announced a financing transaction | CI |
05-15 | Bluejay Diagnostics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
-69.16% | 1.09M | |
-39.38% | 8.28B | |
+9.28% | 3.62B | |
-1.48% | 2.24B | |
-22.85% | 1.94B | |
-18.07% | 1.72B | |
+10.53% | 962M | |
+17.17% | 734M | |
-9.17% | 690M | |
-33.88% | 477M |
- Stock Market
- Equities
- BJDX Stock
- News Bluejay Diagnostics, Inc.
- Bluejay Diagnostics, Inc. Completes Planned Clinical Studies for Symphony IL-6 Test